SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD), (Wild type, pre-fusion state) Recombinant Protein
SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD), (Wild type, pre-fusion state) Recombinant Protein
Product Specifications
Product Name Alternative
Cov spike Protein, 2019-nCoV, nCov spike Protein, 2019-nCoV, coronavirus spike Protein, 2019-nCoV, S glycoprotein, COVID-19, S protein, Spike glycoprotein
UniProt
P0DTC2
Tag
His tag at the C-terminus
Source
HEK293 cells
Field of Research
Infectious Disease & Virology
Purity
> 95% by SDS-PAGE.
Bioactivity
Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 S1+S2 ECD (S-ECD) at 2μg/mL (100 μL/well) can bind recombinant Human ACE2 with a linear range of 0.15-3.72 ng/mL
Form
Liquid
Storage Conditions
This product is stable at ≤ -70°C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
Applications Notes
This recombinant protein can be used for SDS-PAGE.
Tested Applications
WB
NCBI Accession Number
YP_009724390.1
Preservative
20mM Tris,250mM NaCl,0.5%TritonX-100, pH 8.0.
AA Sequence
Val11-Gln1208
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog